In 2025, there are several viable alternatives to Aducanumab for treating Alzheimer's. This article discusses six options, including Donepezil, which increases acetylcholine levels, and Lecanemab, known for its antibody targeting Alzheimer's plaque. The pros and cons of each alternative are considered, offering a comprehensive comparison for those exploring treatment choices.